Results 241 to 250 of about 255,027 (296)

Safety, Feasibility, and Preliminary Efficacy of Allogeneic MSCs to Treat Advanced Femoral Head Osteonecrosis (ALOFEM): A Pilot Study in Young Onco-Hematological Patients. [PDF]

Stem Cells Int
Gómez-Barrena E, Padilla-Eguiluz NG, Cabello-Blanco J, Pozo-Kreilinger JJ, Mozo-Del-Castillo Y, Martínez-Muñoz ME, Martín-Donaire T, Zafra R, Duarte RF, Velasco-Iglesias A, Avendaño-Solà C, Payares-Herrera C.   +11 more
europepmc   +1 more source

Perioperative blood transfusion and adverse events in total hip and knee arthroplasty: a TriNetX-based analysis. [PDF]

Front Med (Lausanne)
Hsieh HH, Lin JH, Tzeng HE, Chien JH, Ho TF.   +4 more
europepmc   +1 more source

Facilitating Expedited Drug Approval– the Past, Present, and Future of Clinical Trials for Pediatric Rheumatic Disease

Arthritis Care &Research, Accepted Article.
Pamela F. Weiss, Hermine I. Brunner
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients

Science Translational Medicine, 2020
Donor fecal microbiota transplantation restores gut microbial diversity and reduces graft-versus-host disease in hematopoietic cell transplant recipients.
Y. V. van Lier, M. Davids, N. Haverkate, P. D. de Groot, M. Donker, E. Meijer, F. Heubel-Moenen, E. Nur, S. Zeerleder, M. Nieuwdorp, B. Blom, M. Hazenberg   +11 more
semanticscholar   +1 more source

Allogeneic Marrow Transplantation

Cancer Investigation, 1984
After 15 years of clinical investigation, allogeneic marrow transplantation can be considered the treatment of choice for a variety of hematologic and immunologic diseases. This review has focused upon some of the principles, current results, problems, and future directions in allogeneic marrow grafting.
K M, Sullivan, R, Storb
openaire   +2 more sources

SEROLOGIC ALLOGENEIC CHIMERISM

Transplantation, 1997
At least some transplanted livers secrete soluble human leukocyte antigens (sHLA) of donor phenotype into the body fluids of recipients. The individuals in whom this phenomenon occurs are by definition serologic allogeneic chimeras. Because an allogeneic transplanted liver may induce tolerance to itself and other organs in animals of the donor strain ...
J C, McDonald, I, Adamashvili, G B, Zibari, D F, Aultman, M C, Mancini, R W, McMillan, F B, Gelder   +6 more
openaire   +2 more sources